BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15701835)

  • 1. Mutations and deletions of the CBP gene in human lung cancer.
    Kishimoto M; Kohno T; Okudela K; Otsuka A; Sasaki H; Tanabe C; Sakiyama T; Hirama C; Kitabayashi I; Minna JD; Takenoshita S; Yokota J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):512-9. PubMed ID: 15701835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.
    Okamoto A; Hussain SP; Hagiwara K; Spillare EA; Rusin MR; Demetrick DJ; Serrano M; Hannon GJ; Shiseki M; Zariwala M
    Cancer Res; 1995 Apr; 55(7):1448-51. PubMed ID: 7882351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
    Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
    Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
    Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
    Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
    Pollock PM; Pearson JV; Hayward NK
    Genes Chromosomes Cancer; 1996 Feb; 15(2):77-88. PubMed ID: 8834170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
    Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
    Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.
    Kondo M; Matsuoka S; Uchida K; Osada H; Nagatake M; Takagi K; Harper JW; Takahashi T; Elledge SJ; Takahashi T
    Oncogene; 1996 Mar; 12(6):1365-8. PubMed ID: 8649840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
    Sekido Y; Pass HI; Bader S; Mew DJ; Christman MF; Gazdar AF; Minna JD
    Cancer Res; 1995 Mar; 55(6):1227-31. PubMed ID: 7882313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
    Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and transcriptional map of a 311-kb segment of chromosome 18q21, a candidate lung tumor suppressor locus.
    Yanaihara N; Kohno T; Takakura S; Takei K; Otsuka A; Sunaga N; Takahashi M; Yamazaki M; Tashiro H; Fukuzumi Y; Fujimori Y; Hagiwara K; Tanaka T; Yokota J
    Genomics; 2001 Mar; 72(2):169-79. PubMed ID: 11401430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
    Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer.
    Hibi K; Yamakawa K; Ueda R; Horio Y; Murata Y; Tamari M; Uchida K; Takahashi T; Nakamura Y; Takahashi T
    Oncogene; 1994 Feb; 9(2):611-9. PubMed ID: 8290272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.
    Roche J; Boldog F; Robinson M; Robinson L; Varella-Garcia M; Swanton M; Waggoner B; Fishel R; Franklin W; Gemmill R; Drabkin H
    Oncogene; 1996 Mar; 12(6):1289-97. PubMed ID: 8649831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines.
    Liu CX; Musco S; Lisitsina NM; Forgacs E; Minna JD; Lisitsyn NA
    Cancer Res; 2000 Apr; 60(7):1961-7. PubMed ID: 10766186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
    Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
    Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LKB1 mutation in large cell carcinoma of the lung.
    Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W
    Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
    Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
    Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.